Publications

You can use the filters to show only results that match your interests

Filter publications
352 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences for manufacturers and wholesalers of medicines

  2. Marketing authorisations granted in September 2017

  3. Parallel import licenses granted in September 2017

  4. Human and veterinary medicines: register of licensed wholesale distribution sites

  5. Register of brokers authorised to deal in human medicines

  6. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  7. Medicines: new manufacturing and wholesale dealer licences

  8. Devices which incorporate an ancillary medicinal substance

  9. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  10. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  11. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  12. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  13. Medical devices: software applications (apps)

  14. Marketing authorisations granted in August 2017

  15. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  16. Advertising investigations: August 2017

  17. Guidance on applying human factors to medical devices

    • MHRA
    • Guidance
  18. Parallel import licenses granted in August 2017

  19. Human and veterinary medicines: register of licensed manufacturing sites 2017

  20. Toolkit on the risks of valproate medicines in female patients

  21. Early access to medicines scheme (EAMS) scientific opinion: Alectinib as monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC)

  22. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  23. MHRA: business impact target

    • MHRA
    • Research and analysis
  24. Marketing authorisations granted in July 2017

  25. Parallel import licences granted in July 2017

  26. Widening the availability of naloxone

    • DH, MHRA and PHE
    • Guidance
  27. Human Medicines Regulations 2012 Advisory Bodies annual report 2016

    • MHRA
    • Corporate report
  28. Good clinical practice inspection metrics

  29. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    • MHRA
    • Corporate report
  30. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Closed consultation
  31. Marketing authorisations granted in June 2017

  32. Parallel import licenses granted in June 2017

  33. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  34. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  35. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  36. Notified bodies for medical devices

  37. Medical devices: UK notified bodies

  38. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  39. Better consultations, better evidence

    • MHRA
    • Research and analysis
  40. Advertising investigations: May 2017